Cart
sales@molnova.com
Home - Products - Others - Other Targets - Picenadol

Picenadol

CAS No. 2650427-35-1

Picenadol( —— )

Catalog No. M36214 CAS No. 2650427-35-1

Picenadol (LY 150720) is a racemic mixture of N-methyl-4-phenylpiperidine derivatives with agonist-antagonist opioid properties.Picenadol has central analgesic activity.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 198 Get Quote
5MG 304 Get Quote
10MG 456 Get Quote
25MG 723 Get Quote
50MG 994 Get Quote
100MG 1332 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote
Get Quotation Bulk Inquiry Add to Cart

Biological Information

  • Product Name
    Picenadol
  • Note
    Research use only, not for human use.
  • Brief Description
    Picenadol (LY 150720) is a racemic mixture of N-methyl-4-phenylpiperidine derivatives with agonist-antagonist opioid properties.Picenadol has central analgesic activity.
  • Description
    Picenadol (LY 150720) is a racemic mixture of N-methyl-4-phenylpiperidine derivatives with agonist-antagonist opioid properties.Picenadol has central analgesic activity.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    2650427-35-1
  • Formula Weight
    247.38
  • Molecular Formula
    C16H25NO
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(CC)C1(C(C)CN(C)CC1)C2=CC(O)=CC=C2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog
related products

  • Arjunglucoside I

    Arjunglucoside I has anti-inflammatory activity, it exhibits significant activity against carrageenan-induced paw edema in rat.

  • Remimazolam

    Remimazolam is a benzodiazepine derivative drug as an alternative to the short-acting imidazobenzodiazepine midazolam, for use in induction of anaesthesia and conscious sedation for minor invasive procedures.?Remimazolam was found to be both faster acting and shorter lasting than midazolam, and human clinical trials showed a faster recovery time and predictable, consistent pharmacokinetics, suggesting some advantages over existing drugs for these applications.?

  • L-Gulono-14-lactone

    L-Gulono-14-lactone is a substrate of L-gulono-14-lactone oxidoreductase which catalyzes the last step of the biosynthesis of L-ascorbic (Vitamin) C.

Sign In Join Free